Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,131
Total Claims
$966K
Drug Cost
615
Beneficiaries
$1,571
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-56%
Opioid rate vs peers
1.1% vs 2.6% avg
+47%
Cost per patient vs peers
$1,571 vs $1,068 avg
+44%
Brand preference vs peers
13.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.1%
Opioid Rate
104
Opioid Claims
$906
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,170 claims · $776K
Generic: 7,855 claims · $186K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 84 | $96K |
| Empagliflozin | 79 | $95K |
| Dapagliflozin Propanediol | 55 | $80K |
| Apixaban | 81 | $77K |
| Insulin Glargine/Lixisenatide | 46 | $43K |
| Dulaglutide | 34 | $36K |
| Buprenorphine Hcl/Naloxone Hcl | 135 | $34K |
| Insulin Glargine,hum.Rec.Anlog | 39 | $27K |
| Evolocumab | 34 | $26K |
| Buprenorphine Hcl/Naloxone Hcl | 28 | $24K |
| Rivaroxaban | 23 | $22K |
| Fluticasone/Umeclidin/Vilanter | 24 | $17K |
| Rosuvastatin Calcium | 557 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 15 | $14K |
| Budesonide/Formoterol Fumarate | 28 | $12K |
Prescribing Profile
Patient Profile
74
Avg Age
54%
Female
1.24
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data